Position
Chief Scientific Officer
Company
AiCuris Anti-infective Cures AG
WuppertalBiotechnologyHealth CareTherapeuticsDescription
Aicuris announced the appointment of Jacques Dumas, Ph.D., as Chief Scientific Officer (CSO), effective January 1, 2025. Dr. Dumas brings over 30 years of experience in pharmaceutical research and development (R&D), with a strong track record of advancing innovative medicines in oncology and infectious diseases.
Quick answer
Aicuris Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer (January 8, 2025). AiCuris Anti-infective Cures AG is based in Wuppertal, North Rhine Westphalia, Germany.
- Who is the new Chief Scientific Officer at AiCuris Anti-infective Cures AG?
- AiCuris Anti-infective Cures AG named Jacques Dumas Chief Scientific Officer, announced January 8, 2025.
- What did AiCuris Anti-infective Cures AG announce on January 8, 2025?
- Aicuris announced the appointment of Jacques Dumas, Ph.D., as Chief Scientific Officer (CSO), effective January 1, 2025. Dr. Dumas brings over 30 years of experience in pharmaceutical research and development (R&D), with a strong track record of advancing innovative medicines in oncology and infectious diseases.
- What does AiCuris Anti-infective Cures AG do?
- AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection.
- Where is AiCuris Anti-infective Cures AG based?
- AiCuris Anti-infective Cures AG is based in Wuppertal, North Rhine Westphalia, Germany.
- Which similar companies made leadership changes around the same time?
- Centessa Pharmaceuticals plc (January 8, 2025), Actio Biosciences (January 8, 2025), Noema Pharma (January 8, 2025) and GEMMABio (January 9, 2025) also announced leadership changes within 45 days of AiCuris Anti-infective Cures AG.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Actio Biosciences Appoints Cayce Denton as Chief Financial Officer (January 8, 2025)
- Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- City Therapeutics Appoints Andrew Orth as Chief Executive Officer (January 7, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
Who to call at AiCuris Anti-infective Cures AG, and when
A new leader at AiCuris Anti-infective Cures AG brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day AiCuris Anti-infective Cures AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AiCuris Anti-infective Cures AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AiCuris Anti-infective Cures AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AiCuris Anti-infective Cures AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AiCuris Anti-infective Cures AG changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.